CFGS
GTHX

Concourse Financial Group Securities’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Concourse Financial Group Securities’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-517
Closed -$1.18K – 2408
2024
Q2 		$1.18K Hold
517
– – ﹤0.01% 2101
2024
Q1 		$2.23K Hold
517
– – ﹤0.01% 2034
2023
Q4 		$1.58K Hold
517
– – ﹤0.01% 2053
2023
Q3 		$744 Hold
517
– – ﹤0.01% 2135
2023
Q2 		$1.29K Hold
517
– – ﹤0.01% 2095
2023
Q1 		$1.39K Hold
517
– – ﹤0.01% 2118
2022
Q4 		$2.81K Hold
517
– – ﹤0.01% 1980
2022
Q3 		$6K Hold
517
– – ﹤0.01% 1628
2022
Q2 		$3K Hold
517
– – ﹤0.01% 1991
2022
Q1 		$4K Hold
517
– – ﹤0.01% 1926
2021
Q4 		$5K Hold
517
– – ﹤0.01% 2066
2021
Q3 		$7K Hold
517
– – ﹤0.01% 2004
2021
Q2 		$11K Hold
517
– – ﹤0.01% 1855
2021
Q1 		$12K Buy
+517
New +$12K ﹤0.01% 1726

Concourse Financial Group Securities's GTHX Position: Q3 2024 in Review

Concourse Financial Group Securities sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 517 shares — an estimated $1.18K sold.

Concourse Financial Group Securities first reported a position in GTHX in Q1 2021 and held it in 14 quarters. The position peaked at $12K in Q1 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

  • Concourse Financial Group Securities reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 517 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $1.18K.
  • Concourse Financial Group Securities first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2021 and held it in 14 quarters.
  • Concourse Financial Group Securities's G1 Therapeutics, Inc. Common Stock position peaked at $12K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.